Introduction
One of the aims of our research programme is to determine the molecular architecture of the ion channel buried deep within certain subtypes of glutamic acid-gated receptor (GluR), i.e. ionotropic not metabotropic GluR. This will require an interdisciplinary approach, but selective pharmacological tools are now available with which to begin to classify GluR subtypes. Such tools include polyamine amides, synthetic analogues of certain arthropod toxins. Another aspect of this research is the application of these channel blockers to related signalling systems, e.g. voltage-sensitive Caz+ channels and nicotinic acetylcholine receptors (nAChRs), themselves ligand-gated ion channels (LGICs). Therefore, a practical procedure, to achieve these aims, is the design and development of potent, selective channel blockers, followed by their affinity (radio-and/or photo-) labelling for subsequent more detailed studies of the threedimensional array of the ion channels.
At the commencement of these studies, polyamine amides were unknown as a class of natural products. We now recognize them as including the most potent, selective non-competitive antagonists of certain LGIC receptors. They are amenable to synthetic manipulation, but their high basicity makes them capricious to work with. Polyamines scavenge carbonic acid from the air, they are preferentially soluble in aqueous rather than organic media, and their preparation often requires a number of protecting and deprotecting steps during the synthetic sequence. Nevertheless, these arthropod venom toxins are potentially powerful tools in basic neuroscience. We have also considered the sites and modes of action of the natural and synthetic polyamine amides and modes of action of the natural and synthetic polyamine amides as a function of their pharmacological selectivity. If the exploration of the allosteric effects which allow the control of an ion-channel pentameric protein receptor complex by a charged, low-molecular-mass ligand [147Da L-glutamic acid or its isomer Nmethyl-o-aspartate (NMDA) controls -500 kDa of GluR 146 Da acetylcholine or 162 Da nicotine controls -250kDa of nAChR] were not reason enough to study these gating mechanisms, then the entry of Caz+ into cells through GIuR, and the massive overload of glutamic acid and the associated elevation of intracellular CaL+ concentrations in certain neurodegenerative diseases (e.g. stroke, trauma), makes GluR prime targets for current central nervous system research in the pharmaceutical industry. Ca2+ entry into neurons through voltage-and ligand-gated ion channels, in addition to triggering a variety of physiological processes, contributes to neuronal damage following hypoxic and ischaemic insults. 'Almost everyone knows someone who has had a stroke or head injury.' ... 'someone has a stroke every five minutes somewhere in the UK, and every year one person in 100 has to be taken to hospital with a traumatic brain injury. We already strongly suspect that the damaging processes include entry of calcium ions through pores in the cell membranes. Drugs are being developed that help to combat these molecular processes' [ 11.
Isolation and identification of polyamine-containing toxins
Natural products continue to provide an important source of lead compounds for both pharmaceutical and agrochemical research. The potential role of arthropod (spider and wasp) toxins in the development of selective biochemical/pharmacological tools, and as lead compounds in the drug discovery process, has been significantly increased by the discovery of the low-molecular-mass, non-proteinaceous toxins from various spider genera and from the solitary digger-wasp Philanthus triangulum. Herein, we show how the discovery of these polyamine amide toxins has led to a clearer understanding of the possible biological role(s) of polyamine amides in central nervous function. We present possible targets for drug discovery which may be associated with GluR, we discuss briefly the argiotoxins as representative members of the class of polyamine amides, and we outline the possible sites Volume 22 and modes of actions for these potent natural products and their many synthetic analogues. This area has been the subject of several recent reviews [ 1 a-1 51, and various research groups have summarized their work as well as providing overviews of the general area of polyamine isolation and their mode(s) of action at ionotropic receptors. These reviews, summaries, and book chapters provide a detailed setting for this paper, covering the background and providing the experimental data for the natural product isolation and then the spectroscopic and biological characterization of the various toxins.
Polyamine amides have been isolated, purified, and characterized in many laboratories, including our own. Usherwood et al. [16] first reported that these toxins were low-molecular-mass compounds. Previous studies by Abe et al. [ 171 referred to proteinaceous or high-molecular-mass fractions, typically using gel-filtration (permeation) in the purification procedure of the toxin. Subsequently, other workers described the presence of low-molecular-mass fractions in spider venoms, and eventually polyamine amide toxins were isolated from the venoms of a wide variety of spiders, including: argiotoxins (ArgTX), isolated from the venoms of the orb-web spiders Argiope and Aruneus; Joro spider toxin (JSTX); Nephila chvutu spider toxin (NSTX); agatoxins (AGEI,) and hettoxins; NephiZu peptide-like spider toxins (NPTX); argiopinins and pseudoargiopinins (Figure 1 ). These compounds are generally composed of an aromatic chromophore, a polyamine backbone, and one or more amino acid residues. They all terminate in a primary amino or guanidino functional group, and the synthetic pathways and approaches to these compounds have been comprehensively reviewed [ la-1 51.
Potency, selectivity and novel modes of action
Polyamine amides have been tested in various mammalian and invertebrate pharmacological model systems for their response as channel blockers of excitatory nAChRs, GluRs, and voltagesensitive channels, and inhibitory CI ~ channels. In particular, the neurally evoked twitch contraction of the locust retractor unguis muscle, dissected from the metathoracic leg of adult locust (Schistocercu gregurziz) and mounted in a Perspex perfusion chamber [18] [19] [20] has been extensively developed by Usherwood and his co-workers as a highthroughput invertebrate quisqualic acid (QU1S)-sensitive GluR screen. This preparation is noted for its responsiveness to 1,-glutamic acid through the Polyamine arnide toxins obtained from spider venoms n on presence postjunctionally of QUIS-sensitive receptors at nerve-muscle synapses.
Spermine has previously been shown, using electrophysiological techniques, non-competitively to antagonize locust muscle GluR as outlined above [20,2 13 . Polyamines also potentiate the response to 1,-glutamic acid or NMDA [22-241, and such potentiation has been observed with polyamine amide toxins [24, 25] . Thus, polyamines and polyamine amides both potentiate and antagonize GluR. The spider toxin ArgTX-636 has been identified as a channel blocker of NMDA-gated cation channels [26] , possibly acting at the Mg2+-binding site [27] on the NMDA receptor (NMDAK). Indeed, Mg2+ may be a partial agonist at a polyamine-binding site and arcaine ( 1,4-diguanidinobutane) appears to be a competitive inhibitor at one of the polyamine sites of NMDAR [28] . Polyamines and polyamine amides have been shown to be non-competitive antagonists of rat NMDAR and nAChR using philanthotoxin-4.3.3 (PhTX-4.3.3, 8-philanthotoxin) analogues [24, 29] . Our synthetic analogues also block rat brain GluR, as measured in a corticalwedge, grease-gap assay procedure [30] . The non-competitive antagonism is use-dependent, becoming successively stronger with each of the first three applications of agonist.
In excitable systems, polyamine amides act at a number of sites and have more than one mode of action. NSTX-3 and JSTX-3 increase uptake of glutamic acid at the locust glutamatergic nerve-muscle junction. ArgTX-636 is a postsynaptic antagonist of GluR [25] . An additional postsynaptic effect of ArgTX-636 is its allosteric modulation (potentiation) of transmitter action on GluR, an effect which has also been reported for PhTX-4.3.3 [3 13 . At this synapse, PhTX-4.3.3 acts both presynaptically where it inhibits transmitter uptake and postsynaptically where it antagonises GluR non-competitively. Detailed considerations of the structure-activity relationship profiles of the natural venom toxins, together with those data obtained for the many synthetic analogues of several laboratories, have led to the development of models for the binding of these toxins [ 321. Several mechanisms to account for the non-competitive antagonism of the glutamic acid-gated cation channel by polyamine amides have been proposed, inter a h [ la-5,7-14,32], incorporating: membrane stabilization; voltage-dependent, open-channel block as the polycationic toxins bind to electronrich functional groups in the wall of the selectivity filter; intracellular channel block, and even metalion chelation. This variety of sites and modes of action of the polyamine amides, several models for which are discussed in detail in the reviews, may still allow for selectivity, if not specificity, of action.
Practical syntheses of P hTX-3.4.3, sFTX-3.3 and FTX-3.3
Total syntheses of polyamine amide toxins have been described in the literature, including syntheses of ArgTX-636, NSTX-3, JSTX-3, PhTX-4.3.3, clavamine, NPTX-9, 10, 11, 12, and a-agatoxins (AGEI,) (for recent comprehensive reviews of synthetic work on spider toxins, see [6, 15] ). From the venom of a parasitic wasp, the solitary, beewolf wasp l? triangulum (Sphecidae) which paralyses honeybees [ 331, the polyamine amide PhTX-4.3.3 was identified and isolated. Routes to synthetic analogues and the chemistry of these toxins have been developed in our laboratories [6, 20, 32] . We have developed a rapid, practical synthesis of the wasp toxin analogue PhTX-3.4.3 by mono-acylation of spermine (3.4.3) (Scheme 1). The analogue PhTX-3.4.3, in which the polyamine spermine (3.4.3) replaces the thermospermine (4.3.3) of the natural toxin, is essentially as potent as the natural product. Rapid, practical syntheses of the arginyl polyamine toxin analogue sFTX-3.3, a blocker of voltage-sensitive Caz + channels, have recently been achieved [ 341 from tri-Cbz-1,-arginine (Cbz, benzyloxycarbonyl) (Scheme 2). The putative polyamine spider toxin FTX-3.3 has also been prepared by an unambiguous route [35] (Scheme 3).
PhTX-3.4.3 synthesis
These toxins display a variety of effects on different subclasses of Caz+ channels, and selective channel blockers are required in order to delineate the physiological functions of these ion channels. Quantities of these spider toxins and synthetic polyamine amides are required for biological assess- 
A generalized trend among potent channel-blocking polyamine amides
ArgTX and related polyamine arthropod toxins may be viewed as molecules which contain a phenolic group capable of hydrogen bonding at one end of the molecule, and a protonated guanidino (or amino) functional group at the other end of the molecule (Figure 2 ). These functional groups, the phenol and especially the guanidine, will be charged (partially if not fully) at physiological pH. The spider toxins generally, but not exclusively, have a two-carbon spacer between the chromophore and the first amide bond. The wasp toxin PhTX-4.3.3 (cf. Scheme 1) has a three-carbon spacer in this 6 .0 and 8.7 p M respectively. This is significant, as it demonstrates that the removal of the n-butanoyl side-chain, together with the primary amine group from the 1.-tyrosine residue (i.e. incorporation of the achiral 4-hydroxyphenylalkanoic acids as the aromatic chromophore), raises potency. ArgTX-636 has an ICpo of the order of 1 p M when tested on the locust nerve-muscle preparation. Thus, the binding of the 1,-asparagine and I,-arginine residues, although not essential for activity, may be of significance for further increasing the potency of the analogues, and experiments to verify this are in progress in our laboratories. The acylated polyamines are synthetic polyamine amides. The natural products NSTX-3 and JSTX-3 each contain a /3-alanine residue and they are polyamine amide hybrids compared with the spider toxins ArgTX-636, ArgTX-659, and ArgTX-673 (see Figure 1) .
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Concluding remarks
Polyamine amides constitute novel, low-molecularmass, polar compounds which are lead structures for the further advancement of the drug discovery process. Their high polarity may present some significant difficulties in selective drug delivery and targeting, but this could be offset, in part, by their high potency. The possible treatment of acute ischaemic damage, whether focal or global, including prophylactic protection from stroke and epileptic attacks, has not yet ben assessed clinically using polyamine amides, due to their scarcity as natural products. Seymour Polyamine amides are potent, non-competirive antagonists of certain 1,GICs. However, although these toxins from wasps and spiders 141 1, and their many synthetic analogues, are not selective between GluRs and nAChRs. they are polyamine-containing channel blockers which form an exciting new class of biologically active, low-molecular-mass compounds.
